Maresins: anti-inflammatory pro-resolving mediators with therapeutic potential

Eur Rev Med Pharmacol Sci. 2020 Jul;24(13):7442-7453. doi: 10.26355/eurrev_202007_21913.

Abstract

Although inflammation is protective of the body, uncontrolled acute inflammatory reactions may inflict tissue damage and lead to chronic inflammation. There is a fast-growing research interest in mechanisms that mediate regression of inflammation and actions of anti-inflammatory factors. Studies of inflammatory and anti-inflammatory mechanisms have uncovered roles for new lipid mediators, including lipoxins, resolvins, protectins, and maresins, collectively referred to as specialized pro-resolving mediators (SPM). Maresins have recently been discovered and are biosynthesized from docosahexaenoic acid (DHA) by macrophages and display strong anti-inflammatory and pro-resolving activities. Here, we summarize the actions and mechanisms of maresins in different diseases and suggest possible therapeutic uses.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Docosahexaenoic Acids / metabolism*
  • Docosahexaenoic Acids / therapeutic use
  • Humans
  • Inflammation / drug therapy
  • Inflammation / immunology
  • Inflammation / metabolism*
  • Inflammation Mediators / metabolism*
  • Signal Transduction

Substances

  • 13,14-dihydroxydocosahexaenoic acid
  • 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid
  • Anti-Inflammatory Agents
  • Inflammation Mediators
  • Docosahexaenoic Acids